Study Shows MicroRNA-Based Diagnostic Identifies Squamous Lung Cancer With 96% Sensitivity

Rosetta Genomics Ltd. (Nasdaq:ROSG) and collaborators announced the results of a research study, showing for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity. The study, posted on the Journal of Clinical Oncology’s Web site,[1] was carried out in collaboration with researchers at Columbia University, NYU Cancer [...]

Red Wine Vs. White? It Makes No Difference When It Comes To Breast-Cancer Risk

The largest study of its kind to evaluate the effect of red versus white wine on breast-cancer risk concludes that both are equal offenders when it comes to increasing breast-cancer risk. The results of the study, led by researchers at Fred Hutchinson Cancer Research Center, were published in the March issue of Cancer Epidemiology, Biomarkers [...]

FDA Clearance For DVS(R)-HFT, Next-Generation Wireless Sensor To Measure Actual Radiation Dose At Breast And Prostate Tumor Site

Sicel Technologies, Inc. announced it has received clearance from the U.S. Food and Drug Administration to begin marketing DVS®-HFT, the next-generation of the company’s original DVS (Dose Verification System) wireless implantable dosimeter that remains the only device to measure actual radiation dose at the tumor site for use in treating breast and prostate cancer patients [...]

Multi-million Funded Experiments Could Lead To Revolution In Cancer Treatment

From Monday 9th March, scientists at the Science and Technology Facilities Council’s Rutherford Appleton Laboratory will begin preparatory experiments ahead of a major joint project with King’s College London. The aim of the work is to gain a better understanding of how new drugs could be developed to help treat cancer. Ultimately the scientists want [...]

Discovery Of Gene Mutations That Cause Childhood Brain Cancer

Researchers funded by the Canadian Cancer Society have discovered eight similar genes that, when mutated, appear to be responsible for medulloblastoma – the most common of childhood brain cancers. The findings are published in the online edition of the journal Nature Genetics. “This discovery is very promising and may help researchers develop better, more targeted [...]

Protein Helps Immune Cells To Divide And Conquer

Researchers at the University of California, San Diego School of Medicine have identified a key protein that is required for immune cells called B lymphocytes to divide and replicate themselves. The rapid generation of large numbers of these immune cells is critical to the body’s antibody defense mechanism. However, when B cells grow unchecked, it [...]

Digestive CARE™ Gastroenterologists Launch ‘Bottom Line Poetry Contest’ For National Colorectal Cancer Awareness Month During March 2009

Digestive CARE™, a medical group of 46 gastroenterologists in Broward and Palm Beach County, today launched the “Bottom Line Poetry Contest” in honor of National Colorectal Cancer Awareness Month (March 2009). Digestive CARE™ is offering a $500 cash prize (or the option of a free colonoscopy) to the poet who submits the best new original [...]

ASTRO’s Patient Education Program Wins National Award

The American Society for Radiation Oncology (ASTRO) has been selected as one of only 21 organizations nationwide to receive an Award of Excellence in the first round of the 2009 Associations Advance America (AAA) Awards, which is a national competition sponsored by the American Society of Association Executives and the Center for Association Leadership in [...]

Addition Of Chemotherapy To Radiotherapy Continues To Increase Survival In Patients With Brain Tumours For Up To 5 Years, The Lancet

Giving patients with glioblastoma-the most common and aggressive form of primary brain tumour-the chemotherapy drug temozolomide in combination with radiotherapy increases their survival compared with those receiving radiotherapy alone and this improvement persists for up to 5 years, according to the final results of the EORTC-NCIC trial*, published Online first and in the May edition [...]

New Therapy Surprisingly Successful For Brain Tumors

The combination of two drugs produces a critical improvement in the treatment of certain brain tumours. This has been demonstrated by researchers at Bonn University working in co-operation with German and Swiss colleagues in a current study. They treated 39 patients who had been diagnosed with a so-called gliablastoma. The patients survived on average 23 [...]